Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and external validation of a FDG PET-based radiomics model predicting occult lymph node metastasis in non-small cell lung cancer patients.

European journal of nuclear medicine and molecular imaging·2026
Same author

Radiotherapy modification based on artificial intelligence and radiomics applied to (<sup>18</sup>F)-fluorodeoxyglucose positron emission tomography/computed tomography.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023
Same author

[Comparative analysis of the brain distribution of [18F]FDG in populations of patients with Alzheimer's disease with or without family history of dementia].

Revue medicale de Liege·2022
Same author

[<sup>18</sup>F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort.

European journal of nuclear medicine and molecular imaging·2021
Same author

[Concepts of medical imaging in the work up and follow-up of cancer : oncological imaging at a glance].

Revue medicale de Liege·2021
Same author

Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework.

Methods (San Diego, Calif.)·2020

Related Experiment Video

Updated: Jun 6, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Chorea associated with anti-phospholipid antibodies: case report.

J Demonty1, M Gonce, P Ribai

  • 1Service des Maladies Infectieuses et de Médecine Interne Générale, Centre Hospitalier Universitaire de Liège, Liège, Belgique. jean.demonty@chu.ulg.ac.be

Acta Clinica Belgica
|December 7, 2010
PubMed
Summary
This summary is machine-generated.

A rare case of chorea in a teenager was successfully treated with steroids and aspirin. This autoimmune condition, linked to antiphospholipid syndrome, showed significant improvement with targeted therapy.

More Related Videos

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Related Experiment Videos

Last Updated: Jun 6, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
11:03

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Background:

  • Chorea is a neurological movement disorder characterized by involuntary, irregular, and unpredictable movements.
  • Antiphospholipid syndrome (APS) is an autoimmune disorder associated with an increased risk of blood clots and pregnancy complications.

Observation:

  • A 17-year-old male presented with acute-onset chorea affecting all four limbs.
  • Genetic testing for Fibrillin 1, familial chorea, and Huntington's disease was negative.
  • High levels of anti-beta2-GP1 IgG, anticardiolipin antibodies, and lupus anticoagulant were detected, indicative of APS.

Findings:

  • Brain imaging (EEG, MRI) revealed no structural abnormalities.
  • Positron Emission Tomography (PET) scan showed bilateral striatal hypermetabolism.
  • Treatment with methylprednisolone and low-dose aspirin led to complete resolution of choreic movements within two months.
  • Follow-up PET scan demonstrated a reversion of striatal hypermetabolism to a normal pattern.

Implications:

  • This case highlights a rare presentation of chorea secondary to antiphospholipid syndrome.
  • Early diagnosis and treatment with immunosuppressants and anticoagulants can lead to favorable outcomes in APS-related chorea.
  • The findings suggest a potential autoimmune or inflammatory mechanism underlying striatal dysfunction in APS.